Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Cannabidiol Capsule Usage as an Adjunct Therapy for Crohn's Disease
NCT03467620Phase 3Withdrawn
- Sponsor
- University of Illinois Chicago
- Start
- Jul 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cannabidiol in Crohn's disease, sponsored by University of Illinois Chicago. Planned start Jul 2018; status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03467620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03467620.